AG˹ٷ

STOCK TITAN

[Form 4] McEwen Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

McEwen Inc. director Michael Nelson Melanson was granted 10,000 stock options on 08/11/2025 with an exercise (conversion) price of $10.43. The filing reports these options as directly beneficially owned by Mr. Melanson following the grant and shows no cash purchase associated with the grant.

The options vest in three equal annual installments beginning August 11, 2026 and expire on August 11, 2030. The filing is a single-person Form 4 reporting this equity award to a company director; it contains no other transactions, cash exercises, or changes in outstanding common stock reported.

McEwen Inc. l'amministratore Michael Nelson Melanson ha ricevuto 10,000 stock options il 08/11/2025 con un prezzo di esercizio (di conversione) di $10.43. La segnalazione indica queste opzioni come possedute direttamente dal sig. Melanson dopo la concessione e non riporta alcun acquisto in contanti collegato alla concessione.

Le opzioni maturano in tre rate annuali uguali a partire dal August 11, 2026 e scadono il August 11, 2030. La comunicazione è un Modulo 4 relativo a una sola persona che dichiara questo premio azionario a un amministratore; non contiene altre transazioni, esercizi in contanti o modifiche dell'azionariato comune segnalate.

McEwen Inc. el director Michael Nelson Melanson recibió 10,000 stock options el 08/11/2025 con un precio de ejercicio (de conversión) de $10.43. La presentación informa que estas opciones son de propiedad directa del Sr. Melanson tras la concesión y no muestra ninguna compra en efectivo asociada.

Las opciones se consolidan en tres cuotas anuales iguales a partir del August 11, 2026 y vencen el August 11, 2030. La presentación es un Formulario 4 de una sola persona que reporta esta concesión de capital a un director de la compañía; no contiene otras transacciones, ejercicios en efectivo ni cambios reportados en las acciones ordinarias en circulación.

McEwen Inc. 이사 Michael Nelson Melanson에게 10,000 stock options08/11/2025� 부여되었으�, 행사가�(전환가�)은 $10.43입니�. 제출서는 해당 부� � � 옵션들이 Melanson 씨의 직접� 수익 보유� 보고되었으며, 부여와 관련된 현금 매입은 없다� 기재하고 있습니다.

� 옵션은 August 11, 2026부� 시작� 3회의 동일� 연간 분할� 권리가 취득되며, 만료일은 August 11, 2030입니�. � 제출서는 회사 이사� 대� 단일 인물� Form 4� � 주식지급을 보고� 것이�, 다른 거래� 현금 행사, 발행주식� 변경에 대� 보고� 포함되어 있지 않습니다.

McEwen Inc. l'administrateur Michael Nelson Melanson s'est vu accorder 10,000 stock options le 08/11/2025 avec un prix d'exercice (de conversion) de $10.43. Le dépôt indique que ces options sont détenues directement par M. Melanson après l'octroi et ne fait état d'aucun achat en espèces lié à l'attribution.

Les options s'acquièrent en trois tranches annuelles égales à partir du August 11, 2026 et expirent le August 11, 2030. Le dépôt est un formulaire 4 individuel signalant cette attribution d'actions à un administrateur de la société ; il ne contient aucune autre transaction, exercice en numéraire ou modification des actions ordinaires en circulation signalée.

McEwen Inc.-Direktor Michael Nelson Melanson wurde am 08/11/2025 10,000 stock options mit einem Ausübungspreis (Umwandlungspreis) von $10.43 gewährt. Die Meldung weist diese Optionen nach der Zuteilung als direkt vorteilhaftes Eigentum von Herrn Melanson aus und verzeichnet keinen mit der Zuteilung verbundenen Barerwerb.

Die Optionen werden in drei gleichen jährlichen Tranchen ab dem August 11, 2026 unverfallbar und verfallen am August 11, 2030. Die Meldung ist ein Einzelpersonen-Formular 4, das diese Aktienzuteilung an einen Unternehmensdirektor berichtet; es enthält keine weiteren Transaktionen, Barausübungen oder gemeldeten Änderungen des ausstehenden Stammkapitals.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: A routine director option grant of 10,000 options at $10.43 with multi-year vesting; notable for alignment, not a material event.

The grant of 10,000 stock options at an exercise price of $10.43 is reported as directly owned by the director. The options vest in three equal annual installments starting 08/11/2026 and expire 08/11/2030. From a securities perspective this is a standard equity-compensation event designed to align management/director incentives with shareholder value over time. The filing shows no disposition or exercise activity tied to this transaction.

TL;DR: Time-based vesting ties the director to long-term performance; direct ownership simplifies disclosure and governance tracking.

This Form 4 documents a time-based option award to a director with a clear vesting schedule—three equal annual installments beginning 08/11/2026—which supports retention and alignment objectives. The direct ownership form indicates the director holds the options personally rather than through an indirect vehicle. The disclosure is complete regarding vesting and expiration dates but does not include additional context such as grant rationale or total outstanding option pool size.

McEwen Inc. l'amministratore Michael Nelson Melanson ha ricevuto 10,000 stock options il 08/11/2025 con un prezzo di esercizio (di conversione) di $10.43. La segnalazione indica queste opzioni come possedute direttamente dal sig. Melanson dopo la concessione e non riporta alcun acquisto in contanti collegato alla concessione.

Le opzioni maturano in tre rate annuali uguali a partire dal August 11, 2026 e scadono il August 11, 2030. La comunicazione è un Modulo 4 relativo a una sola persona che dichiara questo premio azionario a un amministratore; non contiene altre transazioni, esercizi in contanti o modifiche dell'azionariato comune segnalate.

McEwen Inc. el director Michael Nelson Melanson recibió 10,000 stock options el 08/11/2025 con un precio de ejercicio (de conversión) de $10.43. La presentación informa que estas opciones son de propiedad directa del Sr. Melanson tras la concesión y no muestra ninguna compra en efectivo asociada.

Las opciones se consolidan en tres cuotas anuales iguales a partir del August 11, 2026 y vencen el August 11, 2030. La presentación es un Formulario 4 de una sola persona que reporta esta concesión de capital a un director de la compañía; no contiene otras transacciones, ejercicios en efectivo ni cambios reportados en las acciones ordinarias en circulación.

McEwen Inc. 이사 Michael Nelson Melanson에게 10,000 stock options08/11/2025� 부여되었으�, 행사가�(전환가�)은 $10.43입니�. 제출서는 해당 부� � � 옵션들이 Melanson 씨의 직접� 수익 보유� 보고되었으며, 부여와 관련된 현금 매입은 없다� 기재하고 있습니다.

� 옵션은 August 11, 2026부� 시작� 3회의 동일� 연간 분할� 권리가 취득되며, 만료일은 August 11, 2030입니�. � 제출서는 회사 이사� 대� 단일 인물� Form 4� � 주식지급을 보고� 것이�, 다른 거래� 현금 행사, 발행주식� 변경에 대� 보고� 포함되어 있지 않습니다.

McEwen Inc. l'administrateur Michael Nelson Melanson s'est vu accorder 10,000 stock options le 08/11/2025 avec un prix d'exercice (de conversion) de $10.43. Le dépôt indique que ces options sont détenues directement par M. Melanson après l'octroi et ne fait état d'aucun achat en espèces lié à l'attribution.

Les options s'acquièrent en trois tranches annuelles égales à partir du August 11, 2026 et expirent le August 11, 2030. Le dépôt est un formulaire 4 individuel signalant cette attribution d'actions à un administrateur de la société ; il ne contient aucune autre transaction, exercice en numéraire ou modification des actions ordinaires en circulation signalée.

McEwen Inc.-Direktor Michael Nelson Melanson wurde am 08/11/2025 10,000 stock options mit einem Ausübungspreis (Umwandlungspreis) von $10.43 gewährt. Die Meldung weist diese Optionen nach der Zuteilung als direkt vorteilhaftes Eigentum von Herrn Melanson aus und verzeichnet keinen mit der Zuteilung verbundenen Barerwerb.

Die Optionen werden in drei gleichen jährlichen Tranchen ab dem August 11, 2026 unverfallbar und verfallen am August 11, 2030. Die Meldung ist ein Einzelpersonen-Formular 4, das diese Aktienzuteilung an einen Unternehmensdirektor berichtet; es enthält keine weiteren Transaktionen, Barausübungen oder gemeldeten Änderungen des ausstehenden Stammkapitals.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Melanson Michael Nelson

(Last) (First) (Middle)
C/O MCEWEN INC.
150 KING STREET WEST, SUITE 2800

(Street)
TORONTO A6 M5H 1J9

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
McEwen Inc. [ MUX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $10.43 08/11/2025 A 10,000 (1) 08/11/2030 Common Stock 10,000 $0 10,000 D
Explanation of Responses:
1. The option vests in three equal annual installments, beginning August 11, 2026.
/s/ Michael Nelson Melanson 08/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Michael Nelson Melanson report on the Form 4 for McEwen Inc. (MUX)?

He reported a grant of 10,000 stock options on 08/11/2025 with an exercise price of $10.43, held directly.

When do the options granted to the MUX director vest and expire?

The options vest in three equal annual installments beginning August 11, 2026 and expire on August 11, 2030.

Does the Form 4 show the options were exercised for cash?

No. The filing shows the grant of options and lists the price as the exercise/conversion price $10.43; there is no reported cash exercise associated with this transaction.

What is the reporting relationship of Michael Nelson Melanson to McEwen Inc. (MUX)?

The Form 4 identifies Michael Nelson Melanson as a Director of McEwen Inc.

Was this Form 4 filed by more than one reporting person?

No. The filing indicates it was submitted by one reporting person.
Mcewen Mng Inc

NYSE:MUX

MUX Rankings

MUX Latest News

MUX Latest SEC Filings

MUX Stock Data

624.93M
45.60M
15.7%
43.7%
9.23%
Other Precious Metals & Mining
Gold and Silver Ores
Canada
TORONTO